 |
Return Create A Forum - Home |
 |
--------------------------------------------------------- |
|
MS Speaks |
 |
https://msspeaks.createaforum.com |
|
--------------------------------------------------------- |
|
***************************************************** |
|
Return to: AMPYRA (dalfampridine) |
|
***************************************************** |
|
#Post#: 2732-------------------------------------------------- |
|
Dalfampridine and liver injury research information (PubMed) |
|
By: agate Date: November 24, 2019, 7:39 pm |
|
--------------------------------------------------------- |
|
[font=comic sans ms]Below is a link to the Overview section of |
|
the report from the National Institute of Diabetes and Digestive |
|
and Kidney Diseases report, [/font]LiverTox: Clinical Research |
|
Information on Drug-Induced Liver Injury. The likelihood score |
|
for Ampyra (dalfampridine) is E ("unproven although suspected |
|
rare cause of clinically apparent liver injury"). |
|
https://www.ncbi.nlm.nih.gov/books/NBK548455/#Dalfampridine.OVERVIEW |
|
***************************************************** |
